Xinhua Pharmaceutical (000756.SZ) subsidiary obtains registration certificate for ursodeoxycholic acid capsules

Zhijian Finance APP News, Xinhua Pharmaceutical (000756.SZ) announced that its wholly-owned subsidiary, Shandong Zibo Xinda Pharmaceutical Co., Ltd. (referred to as "Xinda Pharmaceutical"), has received the "Drug Registration Certificate" issued by the National Medical Products Administration for ursodeoxycholic acid capsules. This drug is used for the treatment of gallbladder cholesterol stones (must be stones that can be penetrated by X-rays, and the gallbladder contraction function must be normal); cholestatic liver diseases (such as primary biliary cirrhosis); and bile reflux gastritis.